Salazosulfapyridine suppresses chondrocyte mediated degradation induced by interleukin 1β

Journal of Rheumatology

Volumn 24, Issue 3, 1997, Pages 550-554

  Nose, Masafumi ^a   Sasano, Minoru ^a,b   Kawashima, Yoichi ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b Pharmacology   (Japan)

Author keywords

articular cartilage; glycosaminoglycans; metalloproteinases; methotre xate; sulfasalazine

Indexed keywords

GLYCOSAMINOGLYCAN; METALLOPROTEINASE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; PRIORITY JOURNAL; RABBIT;

ANIMALS; CARTILAGE, ARTICULAR; CELL SURVIVAL; DINOPROSTONE; GLYCOSAMINOGLYCANS; INTERLEUKIN-1; KNEE JOINT; METALLOENDOPEPTIDASES; METHOTREXATE; RABBITS; SULFASALAZINE;

EID: 0030973911     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pettipher ER, Higgs GA, Henderson B: Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986;83:8749-53.
2. Goldberg RL, Spirito S, Doughty JR, di Pasquale G: Release of cell surface proteoglycan from chondrocytes by interleukin-1. Agents Actions 1993;39:C163-5.
3. Gilman SC: Activation of rabbit articular chondrocytes by recombinant human cytokines. J Rheumatol 1987;14:1002-7.
4. Schnyder J, Payne T, Dinarello CA: Human monocyte or recombinant interleukin 1's are specific for the secretion of a metalloproteinase from chondrocytes. J Immunol 1987;138:496-503.
5. Hasty KA, Reife RA, Kang AH, Stuart JM: The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990;33:388-97.
6. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW: Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
7. Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB: Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;8646:1036-8.
8. Benya PD, Padilla SR, Nimni ME: The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II. Verifications by cyanogen bromide peptide analysis. Biochem 1977;16:865-72.
9. Pelletier JP, McCollum R, DiBattista J, Loose LD, Cloutier JM, Martel-Pelletier J: Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs. Arthritis Rheum 1993;36:1517-27.
10. Shinkai H, Nagai Y: A latent collagenase from embryonic human skin explants. J Biochem 1977;81:1261-8.
11. Chavira R Jr, Burnett TJ, Hageman JH: Assaying proteinases with azocoll. Anal Biochem 1984;136:446-50.
12. Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta 1986;883:173-7.
13. Nagase H, Enghild JJ, Suzuki K, Salvesen G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochem 1990;29:5783-9.
14. Smith RL, Kajiyama G, Lane NE: Nonsteroidal antiinflammatory drugs: Effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro. J Rheumatol 1995;22:1130-7.
15. Firestein GS, Paine MM, Littman BH: Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991;34:1094-105.
16. McCachren SS: Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991;34:1085-93.
17. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH: In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-84.
18. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE: The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
19. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA: Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
20. Hutchinson NI, Lark MW, MacNaul KL, et al: In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1β. Arthritis Rheum 1992;35:1227-33.
21. Yamazaki T, Miyai E, Shibata H, Yamamoto I: Pharmacological studies of salazosulfapyridine (SASP) evaluation of anti-rheumatic action. Pharmacometrics/Oyo yakuri 1991;41:563-74.
22. Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D: A comparison of low dose methotrexate bioavailability: Oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 1993;20:1845-9.
23. Baggott JE, Morgan SL, Ha T, Alarcón GS, Koopman WJ, Krumdieck CL: Antifolates in rheumatoid arthritis: A hypothetical mechanism of action. Clin Exp Rheumatol 1993;(suppl 8)11:S101-5.
24. Selhub J, Dhar GJ, Rosenberg IH: Inhibition of folate enzymes by sulfasalazine. J Clin Invest 1978;61:221-4.
25. Baggott JE, Morgan SL, Ha T, Vaughan WH, Hine RJ: Inhibition of folate dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem J 1992;282:197-202.
26. 2. Inflamm Res 1995;44:178-81.
27. Quinones S, Buttice G, Kurkinen M: Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin-1. Biochem J 1994;302:471-7.
28. Sciavolino PJ, Lee TH, Vilcek J: Interferon-β induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1. J Biol Chem 1994;269:21627-34.
29. Sato H, Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993;8:395-405.
30. Pan L, Eckhoff C, Brinckerhoff CE: Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 1995;57:575-89.
31. Fukuda K, Dan H, Saitoh M, Takayama M, Tanaka S: Superoxide dismutase inhibits interleukin-1-induced degradation of human cartilage. Agents Actions 1994;42:71-3.
32. Gionchetti P, Guarnieri C, Campieri M, et al: Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation. Dig Dis Sci 1991;36:174-8.